Rafarma Pharmaceuticals, Inc. (RAFA)

OTCMKTS · Delayed Price · Currency is USD

0.0310

-0.0060 (-16.22%)

Sep 25, 2026, 1:43 PM EST

Rafarma Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2012	FY 2011
Period Ending	Mar '12 Mar 31, 2012	Mar '11 Mar 31, 2011
Revenue	0.13	0.13
Revenue Growth	0%	-
Cost of Revenue	0.13	0.13
Selling, General & Admin	0.03	0.03
Research & Development	0.08	0.08
Operating Expenses	0.11	0.11
Operating Income	-0.11	-0.11
Interest Expense	-0.01	-0.01
Pretax Income	-0.12	-0.12
Net Income	-0.12	-0.12
Net Income to Common	-0.12	-0.12
Net Income Growth	-	-
Shares Outstanding (Basic)	8	8
Shares Outstanding (Diluted)	8	8
Shares Change	-	-
EPS (Basic)	-0.01	-0.01
EPS (Diluted)	-0.01	-0.01
EPS Growth	-	-

Additional Metrics

Fiscal Year	FY 2012	FY 2011
Period Ending	Mar '12 Mar 31, 2012	Mar '11 Mar 31, 2011
Operating Margin	-81.25%	-81.25%
Profit Margin	-87.92%	-87.92%
EBIT	-0.11	-0.11
EBIT Margin	-81.25%	-81.25%